Blackstone Inc’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Blackstone Inc’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-108,090	Closed	-$6.72M	–	200
2023 Q4	$6.72M	Buy	108,090 +8,090	+8%	+$201K	0.03%	83
2023 Q3	$2.22M	Buy	+100,000	New	+$2.1M	0.01%	107

Blackstone Inc's RYZB Position: Q1 2024 in Review

Blackstone Inc sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 108,090 shares — an estimated $6.72M sold.

Blackstone Inc first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $6.72M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Blackstone Inc reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Blackstone Inc sold 108,090 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $6.72M.
Blackstone Inc first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
Blackstone Inc's RayzeBio, Inc. Common Stock position peaked at $6.72M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Blackstone Inc's 13F filing for Q1 2024, filed 15 May 2024.